In the general news, leaders from France, Germany, and the U.S. met with one another and Russia’s Vladimir Putin to attempt to establish peace in Ukraine. Meanwhile, The U.S. is contemplating sending arms to aid Ukraine. In the U.S., measles continues to spread due to parents who refuse to vaccinate their child, and January added 257,000 jobs for the biggest three-month jobs gain period since 1999.
In healthcare business news, Pfizer (PFE) acquired Hospira (HOSP) for $15 B. Anthem (ANTM) announced that 80 Million insured customers had their sensitive personal data stolen by hackers. MannKind (MNKD) and Sanofi began selling inhaled insulin Afrezza. Actavis (ACT) divested the respiratory drug franchise. Mylan (MYL) acquired a female health line from Famy Care. Regado (RGDO) and Tobira merged to develop NASH drugs. Lastly, in earnings, Edwards (EW) posted strong sales of TAVR valves, and Aetna (AET) raised guidance.
From the FDA, Commissioner Hamburg is stepping down. The Boehringer/Eli-Lilly diabetes combo drug Glyxambi (combines empagliflozin and linagliptin), was approved, as was Roche’s Lucentis to treat diabetics. Also, the FDA’s guidance on how it will regulate smartphone apps was released.